Billiontoone (NASDAQ:BLLN) Upgraded by Wall Street Zen to “Hold” Rating

Wall Street Zen upgraded shares of Billiontoone (NASDAQ:BLLNFree Report) to a hold rating in a report released on Saturday morning.

Billiontoone Stock Up 0.5%

BLLN opened at $90.00 on Friday.

About Billiontoone

(Get Free Report)

BillionToOne is transforming healthcare by redefining molecular diagnostics. Our revolutionary single molecule NGS (smNGS) platform achieves what was once thought impossible – detecting and precisely quantifying genetic targets with single-molecule sensitivity. At the heart of this technological breakthrough lies our patented QCTs, enabling measurements at the physical limit of detection – the single DNA molecule.

See Also

Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.